Department of Medical

Engineering and Biotechnology

Road and rail links

Graduation
Successful completion means graduates are awarded the
internationally recognised academic degree Master of Science
(M. Sc.) from the Ernst Abbe University of Applied Sciences.

Entrance Requirements

Pharmaceutical
Biotechnology

Campus der EAH Jena

Carl-Zeiss-Promenade 2

The accredited Master's course is open to graduates of the

Biotechnology Bachelor's course as well as to graduates of related
Bachelor's courses. A specified selection process is used for decisions
about admissions onto the course.

Career Prospects

Master's Degree
Course

Campus map

Building 1
Building 2
Building 3
Building 4
Building 5

6
7
8
9

Refectory
Carl Zeiss Jena GmbH
Halls of residence
University sports centre

Contact

Successfully accredited by ACQUIN

Dean's office

Phone: +49 (0)3641 205-600, Fax: +49 (0)3641 205-601

Email: mt@fh-jena.de

Specialist
course advisor

Prof. Christina Schumann

Phone: +49 (0)3641 205-614
Christina.Schumann@fh-jena.de

www.mt.fh-jena.de

Carl-Zeiss-Promenade 2, Postfach 10 03 14, 07703 Jena, Germany

www.mt.fh-jena.de

M. Sc.
Pharmaceutical
Biotechnology

All information can be subject

to additional change. No legally
binding claims can be inferred
from this informational flyer.

1
2
3
4
5

Photos: EAH Jena, S. Reuter

The Master's degree enables graduates to work in the civil service for
a career on higher management level and also the opportunity to study
for a PhD (mainly research-centric course).

As of: October 2014

Pharmaceutical Biotechnology is currently enjoying the greates

groth rate in the biotechnology sector. The transfer of findings
from fundamental, modern cell and molecular-biological research
to innovative pharmaceutical products for diagnosis and therapy
of illnesses such as cancer, cardiovascular diseases, diabetes and
illnesses of the immune system, offer high growth and employment
opportunities in Germany, particularly in consideration of demographic
developments in Western industrial nations.

www.fh-jena.de

1st Semester

Low-molecule
Pharmaceutical
Agents

2nd Semester

Biophysics 2

3rd Semester

Elective Module

Bioprocess
Development

GMP/ Approval
Procedures
Bio-VT /
Modelling

Elective Module

Genetic
Engineering

Molecular Test
Systems

4th Semester
Elective Module
(example)

Molecular Cell
Biology

Protein
Engineering

Bioprocess Control

Enzyme Technology
Recombinant
Products
Applied
Pharmacology /
Toxicology

Protein
Analysis

Molecular
Medicine

Bioinstruments

Master Thesis and Colloquium

Proteomics

Molecular Tools

Bioethics

Medical Imaging

An up-to-date list is created for the elective modules on a semester by semester basis.

Course Contents and Objectives

The biotechnological application in the field of human medicine
represents the content of the Pharmaceutical Biotechnology Master's
course. Graduates are able to understand the molecular and cellular
mechanisms of the regulation of metabolism processes and their
pathological changes in the development of illnesses, and to use this
knowledge in the development and production of pharmaceuticals
oriented towards human application.
The Pharmaceutical Biotechnology course is currently the only course of
its kind in Central Germany. The specific profile of the Master's course
is derived from the clear-cut focus on biotechnological applications
in the field of human medicine. This subarea of biotechnology
is covered over its entire breadth - from the molecular target to
sellable biotechnologically produced pharmaceutical products. In
contrast to classic biotechnology, with strong instrumentation and
process characterisation, students are taught specialised knowledge
essential for understanding the development of illnesses and the
effect mechanisms of pharmaceutical products. The course differs
from "molecular-biochemical only" tuition courses in that it has strict
orientation towards the development of new products and services.

Employment Opportunities
The Pharmaceutical Biotechnology course has a clear focus on
biotechnological applications in the field of human medicine. Graduates
are able to understand the molecular and cellular mechanisms of the

regulation of metabolism processes and their pathological changes

in the development of illnesses, and to use this knowledge in the
development and production of pharmaceuticals oriented towards
human application. Graduates are able to carry out research and
development work and research-intensive services on a biochemical
and molecular cytological and instrumentation-related level.
They contribute greatly towards the development and production of:
a.) Therapeutic agents made of low-molecular and recombinant
bioproducts
b.) Diagnostic agents with biochemical and molecular cell
biological basis
c.) Analytical biochemical and molecular cytological R&D tools

Course Overview
The normal duration of the Pharmaceutical Biotechnology Master's
course is four semesters. The Master's degree provides first and
foremost subject-specific specialisation in the fields of recombinant
and low-molecular bioproducts, bioprocess engineering, molecular
biology and cell biology, enzyme technology, molecular medicine,
genetic engineering and protein engineering.
The 3rd semester of the curriculum includes two elective modules
each carrying six ECTS credits. The elective modules enable students
to study in greater depth subjects catching their interest and in line
with their preferred areas of work in the future.
The Master's thesis must be completed by students in the last
semester. Scientific mentoring is provided by the relevant institution
or university.

The curriculum has a modular format. For every successfully completed

module, students are awarded a specified number of credit points
in accordance with the European Credit Transfer System (ECTS).
This system simplifies the recognition of course achievement when
students switch to universities at home or abroad.